Kewal Handa
Prior to this, has served as Executive Director - Finance, Pfizer Limited. Also Managing Director of Wyeth Ltd from 2009 to 2012.
Under his leadership, Pfizer India became one of the top ten pharmaceutical companies in India, due to new initiatives and innovative strategies implemented during his term. He has constantly challenged the rules of the game – whether it was making Pfizer India’s first MNC to enter into the branded generics space in India or explore a unique partnership with the Government to increase access.
Building a diverse organization is one of his key focuses. As part of this, he has driven various teams to hire and retain women colleagues in management and most importantly in sales positions – an initiative unheard of in the Indian pharmaceutical industry. He has managed this by sensitization and developing policies that are women friendly. These initiatives are now case studies and were showcased at a ministerial roundtable held in Turkey.
President Samarth Life Sciences since 2015
He and his team are managing multiple functions of the company. Samarth is in the domestic formulations business in the pharmaceutical sector. Under his leadership the company has achieved exponential growth with EBITA of 30%. The company is now in amongst the top 50 pharmaceutical companies in India.
Former Non-Executive Chairman of Union Bank of India.
As a Chairman he focused on performances of the bank, worked on the strategy to set up a new monitoring system, championed the digital initiatives, worked closely on the merger and made union bank one of the leading banks in India.
He has diverse experience in Finance, banking Commercial, Strategy, Business Development, Merger & Acquisition and Corporate Affairs and have also experience in sectors like Engineering, Consumer and Project Finance. In past worked in companies like Vidyut Blades & State Industrial Investment Corporation of Maharashtra (SICOM), Schrader Scoville Duncan.
He has worked in the Domestic & Global Generic Businesses. Has wide experience in markets like US, South East Asia, Africa, Bangladesh, and Sri Lanka.
He is a qualified Management Accountant and Company Secretary and has a Masters Degree in Commerce. Has completed the Pfizer Leadership Development Program from Harvard University and the Senior Management Development Program from IIM, Ahmadabad. Has also done a Certificate course on Marketing Strategy from Columbia Business School, New York.
He was awarded the ‘India CFO 2004 – Excellence in Finance in an MNC’ by International Market – Assessment Group, the Bharat Shiromani Award in 2007 and the Pharma Leaders - Pharma Professional of the year 2010.
Company Board of Directors
He is currently on the Board of,
Listed companies:
- Heubach Colorants India Limited (Term ending in 2025)
- Borosil Limited
- Mukta Arts Limited (Term ending in June 2024)
Unlisted Companies:
- Akums Drugs Pharmaceuticals Limited
- Borosil Scientific Limited (proposed to be listed)
- Wellness Forever Medicare Limited
- Quality Care India Limited
Other Association Affiliations
- All India Management Association (AIIMA) - Past President
- Indian Institute of Management, Ahmedabad (IIMA) – Ex-Board of Governor
- Indian Institute of Management Raipur (IIM Raipur) – Ex-Board of Governor
- Organization of Pharmaceutical Producers of India (OPPI) – Ex-Vice President